HDAC9 and neoplasm: As anti-tumor drugs, HDAC inhibitors(HDACi) can regulate the expression of HR-related genes, induce cell cycle arrest, apoptosis, and differentiation in tumor cells, leading to oxidative stress and DNA damage (136, 137).